ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,272, issued on Jan. 20, was assigned to Schlumberger Technology Corp. (Sugar Land, Texas). "Identifying lost-circulation events in downhole... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,530,027, issued on Jan. 20, was assigned to Hyundai Motor Co. (Seoul, South Korea) and Kia Corp. (Seoul, South Korea). "Central management serv... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,721, issued on Jan. 20, was assigned to New Jersey Institute of Technology (Newark, N.J.). "Ultrasound device for destruction of organic ch... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,531,704, issued on Jan. 20, was assigned to Sharp K.K. (Sakai, Japan). "Terminal devices and base station devices" was invented by Huifa Lin (S... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,530,819, issued on Jan. 20, was assigned to Maplebear Inc. (San Francisco). "Generative model for item image selection" was invented by Levi Bo... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,530,019, issued on Jan. 20, was assigned to KYOCERA Corp. (Kyoto, Japan). "Information processing system" was invented by Tomokazu Fujino (Kyot... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,532,134, issued on Jan. 20, was assigned to Cochlear Ltd. (Macquarie University, Australia). "Advanced artificial sound hearing training" was i... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,530,063, issued on Jan. 20, was assigned to Apple Inc. (Cupertino, Calif.). "Dynamic partitioning a power budget among compute agents of a syst... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,855, issued on Jan. 20, was assigned to CureVac SE (Tubingen, Germany). "KRAS variant mRNA molecules" was invented by Amit Aggarwal (Indian... Read More
ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,737, issued on Jan. 20, was assigned to Genzyme Corp. (Cambridge, Mass.). "Pharmaceutical formulations of tropomyosin related kinase (TRK) ... Read More